Delivery Order SPE2DB20D7061-SPE2DB25FSNY7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of etonogestrel-ethinyl estradiol vaginal rings. This competitively awarded, firm fixed-price delivery order has a ceiling value of $2,331.42 and is scheduled for completion by August 5, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued as a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,408.10 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings on July 24, 2025. This is a firm fixed price, competitively awarded contract with a completion date of July 25, 2025, performed at the contractor's corporate office in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $8,043.85 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and represents a routine pharmaceutical procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Etonogestrel-EE vaginal rings, a contraceptive pharmaceutical product, with a contract value of $1,130.61. The award was made on July 30, 2025, with an ultimate completion date of July 31, 2025, utilizing firm fixed price contracting without a set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Etonogestrel-Ethinyl Estradiol Vaginal Rings. The $2,322.30 firm-fixed-price contract has a July 1, 2022 completion date and was awarded on June 30, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $77,146.62 firm fixed-price contract is for the supply of etonogestrel-EE vaginal rings, a type of contraceptive. The contract has an ultimate completion date of August 19, 2022. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Etonogestrel-EE Vaginal Rings. The contract has a ceiling value of $3,699.36 and a period of performance through April 16, 2025. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
- This delivery order, awarded to AmerisourceBergen Drug Corp on February 12, 2025, provides for the supply of Etonogestrel-EE vaginal ring contraceptives to support military and federal healthcare needs. The $1,673.52 contract represents a firm fixed-price delivery order with an ultimate completion date of February 13, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The award was made on a competitive, non-set-aside basis through the Defense...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Etonogestrel-EE vaginal rings. The contract has a firm fixed price of $3,709.62 and a performance period ending on April 24, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,960.09 firm-fixed-price delivery order is for Etonogestrel-EE vaginal rings, with a completion date of March 7, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB25FSNY7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,228.12 to AmerisourceBergen Drug Corp for the supply of etonogestrel-ethinyl estradiol vaginal rings, with an ultimate completion date of July 22, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceuticals and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen regularly fulfills delivery orders for brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 7/21/25 |